entertainment -WSS

entertainment

author：leisure time 2025-10-06 10:22:45 - browse：392

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： A virus, fished out of a lake, may have saved a man’s life

WSS

H5N1 bird flu virus started spreading in cows in Texas in December

Cancer researcher Catriona Jamieson is sending tumors into space

Bristol 'take

Was Amgen transparent enough on FDA's concern on cancer drug?

Bill would stop addiction treatment from triggering child abuse inquiry

Melinda French Gates resigns from Gates Foundation

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

23andMe had bad news about my health. I wish a person had delivered it

Key Senate committee drafts bipartisan bill to stem drug shortages

Tori Bowie and the unacceptable rates of Black maternal death

Why age limits for politicians are a terrible idea

Novavax promises a turnaround & Lilly roils the obesity market

Why Charlie Gard's case is so disturbing to Americans

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Bird flu outbreak in cows is latest avian flu curveball

DIEP, the 'gold standard' of breast reconstruction, is under threat

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

hotspot

Why age limits for politicians are a terrible idea

Chan Zuckerberg Biohub Chicago to focus on inflammation

Bird flu in milk supply is likely coming from asymptomatic cows

Q&A: Jennifer Adair on making gene therapy available globally

Chan Zuckerberg Biohub Chicago to focus on inflammation

More tobacco lobbyists active in statehouses

entertainment

Wikipedia

hotspot

hotspot